Advertise on podcast: 7 minute Hepatology

Join Prof Ken Liu as we discuss the ins and outs of choosing different systemic therapy of HCC. Check out EASL Deepdive: https://open.spotify.com/episode/3QlE3JUpMjyGYCifmtHWyp Article discussed today: Immune checkpoint inhibitor-related hepatotoxicity: A reviewRemash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 [PMID: 34539139 DOI: 10.3748/wjg.v27.i32.5376] https://www.wjgnet.com/1007-9327/full/v27/i32/5376.htm

Join Dr Richard Skoien and Dr Alison Kearney as we discuss the Hepatocare model and the importance of appropriate and timely palliative care referral. Scottish Guidelines: https://www.palliativecareguidelines.scot.nhs.uk/scottish-palliative-care-guidelines/last-days-of-life-care-around-dying/end-stage-liver-disease/

Join A/Prof Juan Pablo Arab as we discuss using steroids in alcohol associated hepatitis. Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019. Epub 2021 Jun 21. PMID: 34166722; PMCID: PMC11090180. https://pubmed.ncbi.nlm.nih.gov/34166722/

Join A/Prof Juan Pablo Arab as we discuss what is Met-ALD. Article: https://www.journal-of-hepatology.eu/article/S0168-8278(24)02728-4/pdf

Join Dr Vaitiekunas as he interviews Prof Abraldes answering all the important questions regarding beta blockers in cirrhosis. Further reading: Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis https://www.sciencedirect.com/science/article/abs/pii/S0168827825025656

nterested in one of the most unique and trainee focussed hepatology fellowships in Australia? Watch below ⬇️ ⬇️ ⬇️ Opportunity to tailor your experience in: 1. Dedicated HCC clinic including prescribing immunotherapy with incorporated clinical trials 2. Specialised clinics in PBC and PSC-IBD 3. Options to have specialised clinics in complex portal hypertension/advanced hepatology/MASLD/ARLD 4. Dedicated experience as "consultant on the ward" 5. Portal hypertension endoscopy lists 6. Be part of multiple investigator and the latest phase 3 trials 7. International collaborations 8. Learn from experts in clinical, research and public health Join us at the Sunshine Coast. What are you waiting for? To apply: https://lnkd.in/gG9dy_GF Deadline: 16th June

Join A/Prof Eric Orman as we discuss management of hyponatraemia in cirrhosis? EASL: https://www.journal-of-hepatology.eu/article/S0168-8278(18)31966-4/fulltext AASLD: https://journals.lww.com/hep/fulltext/2021/08000/diagnosis,_evaluation,_and_management_of_ascites,.38.aspx AGA: https://www.gastrojournal.org/article/S0016-5085(25)05959-1/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F

Join Prof Elliot Tapper discussing how to manage falls in cirrhosis. Article: Falls are an underappreciated driver of morbidity and mortality in cirrhosis https://journals.lww.com/cld/pages/articleviewer.aspx?year=2022&issue=11000&article=00002&type=Fulltext

Join Prof Elliot Tapper as we discuss how to manage muscle cramps in cirrhosis. Today's article: Muscle cramps in cirrhosis: https://journals.lww.com/cld/pages/articleviewer.aspx?year=2024&issue=01010&article=00004&type=Fulltext

Join Dr Megan van Niekerk as she discusses with Dr Elizabeth Goode on managing cholestasis of pregnancy. Article today: Intrahepatic cholestasis of pregnancy https://journals.lww.com/cld/fulltext/2024/01010/intrahepatic_cholestasis_of_pregnancy.16.aspx

Join Dr Shamya Putta as she discusses with Dr Rajit Gilhotra on endohepatology covering endoscopic guided biopsies and portal pressure measurements. Article: Recent advances in clinical practice endohepatology: the endoscopic liver rush https://gut.bmj.com/content/74/11/1916.long

Join us as we discuss how to manage HPS with Dr Michael Krowka. Learning points: Monitoring HPS, Supplemental oxygen, garlic capsules, liver transplantation and managing post transplantation. ILTS guidelines: https://pubmed.ncbi.nlm.nih.gov/27326810/ Outcomes post liver transplantation: https://pubmed.ncbi.nlm.nih.gov/30487203/

Join Dr Davis from the RBWH as we discuss SIRT, radiation segmentectomy when treating HCC. Covering response rates, curative vs palliative therapy and steps to performing SIRT For further reading check out: https://pubmed.ncbi.nlm.nih.gov/38495257/

Join Prof Tsochatzis as we discuss MASLD Pathway, covering who should be screened, sensitivity of ultrasound, intrpreting iron studies and the impact of alcohol. Also check out The Lancet review article - Screening for advanced steatotic liver disease - https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00097-4/abstract

Join Prof Emmanuel Tsochatzis as we discuss on interpreting and utilising NITs in assessing MASLD. Detecting at-risk steatotic liver disease and liver fibrosis in the community: https://journals.lww.com/hep/fulltext/9900/detecting_at_risk_steatotic_liver_disease_and.1285.aspx